Santen Pharmaceutical
4536.T
#3541
Rank
$4.10 B
Marketcap
$12.76
Share price
-0.15%
Change (1 day)
29.05%
Change (1 year)

Revenue for Santen Pharmaceutical (4536.T)

Revenue in 2026 (TTM): $1.86 Billion USD

According to Santen Pharmaceutical 's latest financial reports the company's current revenue (TTM ) is $1.86 Billion USD. In 2025 the company made a revenue of $1.92 Billion USD a decrease over the revenue in the year 2024 that were of $1.97 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Santen Pharmaceutical from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) $1.86 B-3.08%
2025 $1.92 B-2.33%
2024 $1.97 B-7.54%
2023 $2.13 B4.53%
2022 $2.04 B-13.24%
2021 $2.35 B3.36%
2020 $2.27 B2.08%
2019 $2.22 B7.05%
2018 $2.08 B7.69%
2017 $1.93 B6.35%
2016 $1.81 B12.98%
2015 $1.60 B11.62%
2014 $1.44 B2.72%
2013 $1.40 B-1.54%
2012 $1.42 B-1.67%
2011 $1.44 B17.34%
2010 $1.23 B5.59%
2009 $1.17 B